QSAR models of cytochrome P450 enzyme 1A2 inhibitors using CoMFA, CoMSIA and HQSAR

References

• Zhou , SF , Wang , B , Yang , LP and Liu , JP . 2010 . Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2 . Drug Metab. Rev. , 42 : 268 – 354 .
   PubMed Web of Science ®Google Scholar
• Nebert , DW , Dalton , TP , Okey , AB and Gonzalez , FJ . 2004 . Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer . J. Biol. Chem. , 279 : 23847 – 23850 .
   PubMed Web of Science ®Google Scholar
• Brosen , K . 1995 . Drug interactions and the cytochrome P450 system. The role of cytochrome P450 1A2 . Clin. Pharmacokinet. , 29 ( 1 ) : 20 – 25 .
   PubMedGoogle Scholar
• Pelkonen , O , Turpeinen , M , Hakkola , J , Honkakoski , P , Hukkanen , J and Raunio , H . 2008 . Inhibition and induction of human cytochrome P450 enzymes: Current status . Arch. Toxicol. , 82 : 667 – 715 .
   PubMed Web of Science ®Google Scholar
• Wojcikowski , J , Maurel , P and Daniel , WA . 2006 . Characterization of human cytochrome p450 enzymes involved in the metabolism of the piperidine-type phenothiazine neuroleptic thioridazine . Drug Metab. Dispos. , 34 : 471 – 476 .
   PubMed Web of Science ®Google Scholar
• Wojcikowski , J , Pichard-Garcia , L , Maurel , P and Daniel , WA . 2003 . Contribution of human cytochrome p-450 isoforms to the metabolism of the simplest phenothiazine neuroleptic promazine . Br. J. Pharmacol. , 138 : 1465 – 1474 .
   PubMed Web of Science ®Google Scholar
• Chiaro , CR , Patel , RD , Marcus , CB and Perdew , GH . 2007 . Evidence for an aryl hydrocarbon receptor-mediated cytochrome p450 autoregulatory pathway . Mol. Pharmacol. , 72 : 1369 – 1379 .
   PubMed Web of Science ®Google Scholar
• McIntosh , BE , Hogenesch , JB and Bradfield , CA . 2010 . Mammalian Per-Arnt-Sim proteins in environmental adaptation . Annu. Rev. Physiol. , 72 : 625 – 645 .
   PubMed Web of Science ®Google Scholar
• Guengerich , FP and Shimada , T . 1991 . Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes . Chem. Res. Toxicol. , 4 : 391 – 407 .
   PubMed Web of Science ®Google Scholar
• Ma , Q and Lu , AY . 2007 . CYP1A induction and human risk assessment: An evolving tale of in vitro and in vivo studies . Drug Metab. Dispos. , 35 : 1009 – 1016 .
   PubMed Web of Science ®Google Scholar
• Shimada , T and Guengerich , FP . 2006 . Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons . Chem. Res. Toxicol. , 19 : 288 – 294 .
   PubMed Web of Science ®Google Scholar
• Shimada , T , Murayama , N , Okada , K , Funae , Y , Yamazaki , H and Guengerich , FP . 2007 . Different mechanisms for inhibition of human cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic inhibitors . Chem. Res. Toxicol. , 20 : 489 – 496 .
   PubMed Web of Science ®Google Scholar
• Wang , B and Zhou , SF . 2009 . Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development . Curr. Med. Chem. , 16 : 4066 – 4218 .
   PubMed Web of Science ®Google Scholar
• Foroozesh , M , Primrose , G , Guo , Z , Bell , LC , Alworth , WL and Guengerich , FP . 1997 . Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes . Chem. Res. Toxicol. , 10 : 91 – 102 .
   PubMed Web of Science ®Google Scholar
• Hopkins , NE , Foroozesh , MK and Alworth , WL . 1992 . Suicide inhibitors of cytochrome P450 1A1 and P450 2B1 . Biochem. Pharmacol. , 44 : 787 – 796 .
   PubMed Web of Science ®Google Scholar
• Shimada , T , Yamazaki , H , Foroozesh , M , Hopkins , NE , Alworth , WL and Guengerich , FP . 1998 . Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1 . Chem. Res. Toxicol. , 11 : 1048 – 1056 .
   PubMed Web of Science ®Google Scholar
• Zhu , N , Lightsey , D , Liu , J , Foroozesh , M , Morgan , KM , Stevens , ED and Klein Stevens , CL . 2010 . Ethynyl and propynylpyrene Inhibitors of cytochrome P450 . J. Chem. Crystallogr. , 40 : 343 – 352 .
   PubMed Web of Science ®Google Scholar
• Roberts , ES , Hopkins , NE , Foroozesh , M , Alworth , WL , Halpert , JR and Hollenberg , PF . 1997 . Inactivation of cytochrome P450s 2B1, 2B4, 2B6, and 2B11 by arylalkynes . Drug Metab. Dispos. , 25 : 1242 – 1248 .
   PubMed Web of Science ®Google Scholar
• Shimada , T , Murajama , N , Tanaka , K , Takenaka , S , Imai , Y , Hopkins , NE , Foroozesh , MK , Alworth , WL , Yamazaki , H , Guengerich , FP and Komori , M . 2008 . Interaction of polycyclic aromatic hydrocarbons with human cytochrome P450 1B1 in inhibiting catalytic activity . Chem. Res. Toxicol. , 21 : 2313 – 2323 .
   PubMed Web of Science ®Google Scholar
• Shimada , T , Tanaka , K , Takenaka , S , Foroozesh , MK , Murayama , N , Yamazaki , H , Guengerich , FP and Komori , M . 2009 . Reverse type I binding spectra of human cytochrome P450 1B1 induced by flavonoid, stilbene, pyrene, naphthalene, phenanthrene, and biphenyl derivatives that inhibit catalytic activity: A structure-function relationship study . Chem. Res. Toxicol. , 22 : 1325 – 1333 .
   PubMed Web of Science ®Google Scholar
• Sridar , C , Kent , UM , Noon , K , McCall , A , Alworth , B , Foroozesh , M and Hollenberg , PF . 2008 . Differential inhibition of cytochromes P450 3A4 and 3A5 by the newly synthesized coumarin derivatives 7-coumarin propargyl ether and 7-(4-trifluoromethyl)coumarin propargyl ether . Drug Metab. Dispos. , 36 : 2234 – 2243 .
   PubMed Web of Science ®Google Scholar
• Strobel , SM , Szklarz , GD , He , Y , Foroozesh , M , Alworth , WL , Roberts , ES , Hollenberg , PF and Halpert , JR . 1999 . Identification of selective mechanism-based inactivators of cytochromes P-450 2B4 and 2B5, and determination of the molecular basis for differential susceptibility . J. Pharmacol. Exp. Ther. , 290 : 445 – 451 .
   PubMed Web of Science ®Google Scholar
• Sansen , S , Yano , JK , Reynald , RL , Schoch , GA , Griffin , KJ , Stout , CD and Johnson , EF . 2007 . Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2 . J. Biol. Chem. , 282 : 14348 – 14355 .
   PubMed Web of Science ®Google Scholar
• Sridhar , J , Jin , P , Liu , J , Foroozesh , M and Stevens , CL . 2010 . In silico studies of polyaromatic hydrocarbon inhibitors of cytochrome P450 enzymes 1A1, 1A2, 2A6, and 2B1 . Chem. Res. Toxicol. , 23 : 600 – 607 .
   PubMed Web of Science ®Google Scholar
• Cramer , M , Cramer , RD III and Jones , DM . 1988 . Comparative molecular field analysis. 1. effect of shape on binding of steroids to carrier proteins . J. Am. Chem. Soc. , 110 : 5959 – 5967 .
   PubMed Web of Science ®Google Scholar
• Klebe , G , Abraham , U and Mietzner , T . 1994 . Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity . J. Med. Chem. , 37 : 4130 – 4146 .
   PubMed Web of Science ®Google Scholar
• HQSAR, Tripos Associates, Inc., St Louis, MO, USA
   Google Scholar
• So , SS and Karplus , M . 1997 . Three-dimensional quantitative structure-activity relationships from molecular similarity matrices and genetic neural networks. 2. Applications . J. Med. Chem. , 40 : 4360 – 4371 .
   PubMed Web of Science ®Google Scholar
• So , SS and Karplus , M . 1997 . Three-dimensional quantitative structure-activity relationships from molecular similarity matrices and genetic neural networks. 1. Method and validations . J. Med. Chem. , 40 : 4347 – 4359 .
   PubMed Web of Science ®Google Scholar
• Ghose , AK , Viswanadhan , VN and Wendoloski , JJ . 1999 . A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases . J. Comb. Chem. , 1 : 55 – 68 .
   PubMed Web of Science ®Google Scholar
• Clark , RD , Sprous , DG and Leonard , JM . 2001 . “ Validating models based on large data sets ” . In Rational Approaches to Drug Design , Edited by: Holtje , H-D and Sippl , W . 475 – 485 . Barcelona : Prous Science .
   Google Scholar
• Ashek , A and Cho , SJ . 2006 . A combined approach of docking and 3D QSAR study of beta-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors . Bioorg. Med. Chem. , 14 : 1474 – 1482 .
   PubMed Web of Science ®Google Scholar
• McKendall , M , Smith , T , Ahn , K , Ellis , J , McGee , T , Foroozesh , M , Zhu , N and Stevens , CKL . 2008 . Methoxyflavone inhibitors of cytochrome P450 . J. Chem. Crystallogr. , 38 : 231 – 237 .
   Web of Science ®Google Scholar
• Shimada , T , Tanaka , K , Takenaka , S , Murayama , N , Martin , MV , Foroozesh , M , Yamazaki , H , Guengerich , PF and Komori , M . 2010 . Structure–function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives . Chem. Res. Toxicol. , 23 : 1921 – 1935 .
   PubMed Web of Science ®Google Scholar
• Zhu , N , Lightsey , D , Foroozesh , M , Alworth , W , Chaudhary , A and Stevens , CLK . 2006 . Naphthoflavone propargyl ether inhibitors of cytochrome P450 . J Chem Crystallogr. , 36 : 289 – 295 .
   Web of Science ®Google Scholar
• Sridar , C , Kent , UM , Noon , K , McCall , A , Alworth , B , Foroozesh , M and Hollenberg , PF . 2008 . Differential inhibition of cytochromes P450 3A4 and 3A5 by the newly synthesized coumarin derivatives 7-coumarin propargyl ether and 7-(4-trifluoromethyl)coumarin propargyl ether . Drug Metab Dispos. , 36 : 2234 – 2243 .
   PubMed Web of Science ®Google Scholar
• Bowman , B , Lightsey , D , McKendall , ME , Smith , T , Zhu , N , Stevens , CKL and Foroozesh , M . 2005 . Synthesis of a family of biphenylpropargyl ethers as potential inhibitors of P450 enzymes. X-ray crystal structure of 2,2′-biphenyldipropargyl ether . J. Undergrad. Chem. Res. , 2 : 57 – 61 .
   Google Scholar
• Kelley , AT , Mesbah , JY , McKendall , ME , Smith , TP and Foroozesh , M . 2004 . Synthesis of a family of naphthyl propargyl ethers as potential cytochrome P450 inhibitors . J. Undergrad. Chem. Res. , 3 : 103 – 105 .
   Google Scholar
• Cho , SJ and Tropsha , A . 1995 . Cross-validated R2-guided region selection for comparative molecular field analysis: A simple method to achieve consistent results . J. Med. Chem. , 38 : 1060 – 1066 .
   PubMed Web of Science ®Google Scholar
• Lewis , DF . 2003 . Quantitative structure-activity relationships (QSARs) within the cytochrome P450 system: QSARs describing substrate binding, inhibition and induction of P450s . Inflammopharmacology , 11 : 43 – 73 .
   PubMedGoogle Scholar
• Hansch , C and Leo , A . 1995 . Exploring QSAR , Washington , DC : ACS Books .
   Google Scholar
• Thakur , M , Agarwal , A , Thakur , A and Khadikar , PV . 2004 . QSAR study on phenolic activity: Need of positive hydrophobic term (log P) in QSAR . Bioorg. Med. Chem. , 12 : 2287 – 2293 .
   PubMed Web of Science ®Google Scholar